Mangafodipir as a cardioprotective adjunct to reperfusion therapy: a feasibility study in patients with ST-segment elevation myocardial infarction.
about
Mangafodipir as a cardioprotective adjunct to reperfusion therapy: a feasibility study in patients with ST-segment elevation myocardial infarction.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Mangafodipir as a cardioprotec ...... evation myocardial infarction.
@en
Mangafodipir as a cardioprotec ...... evation myocardial infarction.
@nl
type
label
Mangafodipir as a cardioprotec ...... evation myocardial infarction.
@en
Mangafodipir as a cardioprotec ...... evation myocardial infarction.
@nl
prefLabel
Mangafodipir as a cardioprotec ...... evation myocardial infarction.
@en
Mangafodipir as a cardioprotec ...... evation myocardial infarction.
@nl
P2093
P2860
P50
P356
P1476
Mangafodipir as a cardioprotec ...... levation myocardial infarction
@en
P2093
Mustafa Ali
Patrik Skogvard
Rolf G Andersson
Walid El-Saadi
Werner Puskar
P2860
P356
10.1093/EHJCVP/PVU021
P577
2015-01-01T00:00:00Z